Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05042934
What this trial is testing

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaRecurrent Ewing Sarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003955
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 77
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Study completedNCT00390234
What this trial is testing

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more
National Cancer Institute (NCI) 63
Early research (Phase 1)Study completedNCT00822848
What this trial is testing

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Who this might be right for
Sarcoma
OHSU Knight Cancer Institute 18
Testing effectiveness (Phase 2)Ended earlyNCT02601209
What this trial is testing

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more
National Cancer Institute (NCI) 151
Testing effectiveness (Phase 2)WithdrawnNCT06116578
What this trial is testing

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab

Who this might be right for
Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Testing effectiveness (Phase 2)Active Not RecruitingNCT00508443
What this trial is testing

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

Who this might be right for
Spinal Neoplasms
M.D. Anderson Cancer Center 150
Early research (Phase 1)WithdrawnNCT02839694
What this trial is testing

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Who this might be right for
Neoplasm MetastasisSarcomaNeoplasms, Germ Cell and Embryonal+1 more
National Cancer Institute (NCI)
Very early researchActive Not RecruitingNCT05488366
What this trial is testing

Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
University of California, Irvine 9
Testing effectiveness (Phase 2)Ended earlyNCT03009058
What this trial is testing

Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

Who this might be right for
Metastatic Cancer
Immodulon Therapeutics Ltd 2
Early research (Phase 1)Ended earlyNCT03514407
What this trial is testing

INCB059872 in Relapsed or Refractory Ewing Sarcoma

Who this might be right for
Relapsed Ewing Sarcoma
Incyte Corporation 25
Not applicableLooking for participantsNCT07675967
What this trial is testing

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Who this might be right for
Lung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more
Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Study completedNCT02372006
What this trial is testing

Trial of Afatinib in Pediatric Tumours

Who this might be right for
Neuroectodermal TumorsRhabdomyosarcoma
Boehringer Ingelheim 56
Testing effectiveness (Phase 2)Study completedNCT01913652
What this trial is testing

Ph II Cabazitaxel DD Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
European Organisation for Research and Treatment of Cancer - EORTC 42
Testing effectiveness (Phase 2)Study completedNCT05301764
What this trial is testing

LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Testing effectiveness (Phase 2)Study completedNCT00006234
What this trial is testing

Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone

Who this might be right for
Metastatic CancerSarcoma
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Early research (Phase 1)WithdrawnNCT02059850
What this trial is testing

NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Adult Synovial SarcomaMyxoid/Round Cell LiposarcomaRecurrent Adult Soft Tissue Sarcoma+2 more
Fred Hutchinson Cancer Center
Next Page